These final results, along with a previous report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like actions in mice,2 help the concept of targeting ACKR3 as a novel way to modulate the opioid technique, which could open up new therapeutic avenues for opioid-connect